Clinical Trial Update: Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating MN-221 in patients with Chronic Obstructive Pulmonary Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• MN-221

Snippet

Sponsor: MediciNova | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED